Manager × security

FORMULA GROWTH LTD TNDM holdings history

Who else holds this security? →

TANDEM DIABETES CARE INC · CUSIP 875372203 · CIK 1093219

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, FORMULA GROWTH LTD reported 70.30K TNDM (shares), valued at $1.06M, or 0.37% of its reported non-derivative portfolio. Filed 2026-08-17.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
0.37%
Shares
70.30K
70,304
Reported value
$1.06M
USD

Shares decreased 0.74%; reported value decreased 21.87%, and weight changed -0.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20260.37%70,304SEC filing ↗Filed Aug 17, 2026
Q1 20260.61%70,828SEC filing ↗Filed May 14, 2026
Q4 20250.60%70,919SEC filing ↗Filed Feb 13, 2026
Q3 20250.53%122,096SEC filing ↗Filed Nov 13, 2025
Q2 20250.86%122,096SEC filing ↗Filed Aug 13, 2025
Q1 20250.96%123,945SEC filing ↗Filed May 14, 2025
Q4 20241.54%125,965SEC filing ↗Filed Feb 13, 2025
Q3 20241.87%128,125SEC filing ↗Filed Nov 13, 2024
Q2 20241.82%124,646SEC filing ↗Filed Aug 13, 2024
Q1 20241.40%123,746SEC filing ↗Filed May 14, 2024
Q4 20230.39%40,746SEC filing ↗Filed Feb 13, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20230.39%40,746$1.21MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 13, 2024
Q1 20241.40%123,746$4.38MShares increased 203.70%; reported value increased 263.56%, and weight changed +1.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2024
Q2 20241.82%124,646$5.02MShares increased 0.73%; reported value increased 14.61%, and weight changed +0.42 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2024
Q3 20241.87%128,125$5.43MShares increased 2.79%; reported value increased 8.20%, and weight changed +0.05 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2024
Q4 20241.54%125,965$4.54MShares decreased 1.69%; reported value decreased 16.50%, and weight changed -0.33 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 13, 2025
Q1 20250.96%123,945$2.37MShares decreased 1.60%; reported value decreased 47.66%, and weight changed -0.58 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2025
Q2 20250.86%122,096$2.28MShares decreased 1.49%; reported value decreased 4.17%, and weight changed -0.10 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2025
Q3 20250.53%122,096$1.48MShares unchanged; reported value decreased 34.87%, and weight changed -0.33 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2025
Q4 20250.60%70,919$1.56MShares decreased 41.92%; reported value increased 5.16%, and weight changed +0.07 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 13, 2026
Q1 20260.61%70,828$1.36MShares decreased 0.13%; reported value decreased 12.90%, and weight changed +0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2026
Q2 20260.37%70,304$1.06MShares decreased 0.74%; reported value decreased 21.87%, and weight changed -0.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 17, 2026
FORMULA GROWTH LTD · TANDEM DIABETES CARE INC

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1093219","quarter":"2026Q2","cusip":"875372203"}

get_institutional_manager_history
{"cik":"1093219","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.